Merck & Co. is closing in on an approximately $10 billion deal to acquire respiratory drugmaker Verona Pharma, the Financial ...

July 9 (Reuters) - Merck (MRK.N), opens new tab is nearing a roughly $10 billion deal to buy lung disease-focused biotech ...

Encounter-level factors played a key role in limiting outpatient COVID-19 treatment for Black and Latino patients.

Merck will share new scientific findings from its HIV clinical development programs, including Phase 2 data on the safety and pharmacokinetics of MK-8527, an investigational, novel nucleoside reverse ...